Page 3 - Dwight Gorham News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IntelGenx to Report Third Quarter 2023 Financial Results on November 9, 2023 – Conference Call to Follow

IntelGenx to Report Third Quarter 2023 Financial Results on November 9, 2023 – Conference Call to Follow
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Saint laurentUnited statesAndre godinStephen kilmerHorstg zerbeDwight gorhamSecurities exchangeExchange commissionIntelgenx technologies corpIntelgenx corpGenx technologiesChief executive officerChief financial officerConference call detailsLooking informationSecurities exchange act

IntelGenx to Report Third Quarter 2023 Financial Results on

SAINT LAURENT, Quebec, Nov. 02, 2023 (GLOBE NEWSWIRE) IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical.

United statesSaint laurentAndre godinStephen kilmerHorstg zerbeDwight gorhamSecurities exchangeIntelgenx corpExchange commissionIntelgenx technologies corpGenx technologiesChief executive officerChief financial officerConference call detailsLooking informationSecurities exchange act

IntelGenx to Report Third Quarter 2023 Financial Results on November 9, 2023 – Conference Call to Follow

United statesSaint laurentDwight gorhamAndre godinHorstg zerbeSecurities exchangeExchange commissionIntelgenx technologies corpCfointelgenx corpGenx technologiesChief executive officerChief financial officerConference call detailsLooking informationSecurities exchange actSecurities act

IntelGenx Provides RIZAFILM® U S Commercialization Update

Receives first purchase order from Gensco® PharmaSAINT LAURENT, Quebec, Sept. 21, 2023 IntelGenx Corp. today announced that it has received the first purchase order for RIZAFILM®1 from its.

Saint laurentUnited statesStephen kilmerGensco pharmaDwight gorhamAndre godinPaul zimmermanPharma corporationAmerican migraine foundationIntelgenx technologies corpIntelgenx corpCompany or intelgenxSecurities exchangeExchange commissionRegistered trademarkMigraine drugs market

IntelGenx Provides Regulatory Update for Xiromed-Partnered Development Candidate, Buprenorphine Buccal Film

SAINT LAURENT, Quebec, Sept. 19, 2023 IntelGenx Corp. today provided a regulatory update on Buprenorphine Buccal Film, for which an abbreviated new drug application has been filed with the.

Saint laurentUnited statesAndre godinInsud pharmaIntelgenx versafilmStephen kilmerDwight gorhamExchange commissionDrug administrationChemo researchSecurities exchangeIntelgenx corpCompany or intelgenxIntelgenx technologies corpBuprenorphine buccal filmComplete response letter